Retinitis Pigmentosa: Optimizing Care for Your Patients

Track No. 1: Strategies for the diagnosis and management of retinitis pigme…

Read Article
  • Treatment Paradigms in AMD Management:

    Assessing Consistent Long-Term Dosing

    Read Article
  • Diabetes Awareness Month
  • OCT-A Disease Education Resource Center
  • AMD Awareness Month
  • DME Disease Education Resource Center
  • Uveitis Resource Center
  • ZEISS OCT Angiography eNewsletter Series
  • AMD Disease Education Resource Center
  • Articles From This Issue


    Retinitis Pigmentosa: Optimizing Care for Your Patients

    Cover Stories: Greatest Hits

    Retinitis pigmentosa (RP) is diagnosed in approximately one in every 4000 people, and it is one of the most common inherited retinal diseases in the world. It is character…

    A Retina Mixtape

    Editors’ Message

    Think about your daily routine. What is the role of music in your everyday life? Is it essential to your process or just a welcome piece of background noise? What songs wo…


    Supplements and Inserts

    High-Speed Cutting: Implications for Tractional Forces

    One of the key components of successful and safe retina surgery is the ability to engage target tissue while causing minimal or no disruption of adjacent tissue. Whether dissecting hyaloid near the retina, peeling a membrane, or performing core vitrectomy, the surgeon must be ever mindful of tractional forces and how much stress the intraocular maneuvers are placing on the retina-vitreous interface.

    A Review of DME Treatment Guidelines and the Role of Early Appropriate Therapy

    The prevalence of diabetes is growing globally; as such the number of people affected by vision-threatening diabetic retinopathy (DR) is likewise expected to continue to increase. Prevent Blindness America has estimated more than 7.6 million people in the United States have DR as a result of their systemic disorder.1

    Retina Surgery Without Compromise

    The majority of my cases are operated using 23-gauge instrumentation using valved cannulas whenever possible. While I do use some 25-gauge, I prefer to use the technology with which I am most comfortable. I am not necessarily resistant to change; however, I have been getting very good results with my particular setup for over a decade, and so it is difficult for me to justify modifying my approach.



    Apellis Pharmaceuticals Announces 18-Month Results of Phase 2 Study (FILLY) of APL-2 in Geographic Atrophy

    Apellis Pharmaceuticals will provide an update with 18-month data on its phase 2 trial (FILLY) of its complement C3 inhibitor, APL-2, in patients with geographic atrophy (GA) associated with age-relat…

    Second Sight Announces Market Entry into Singapore with First Implant of Argus II Retinal Prosthesis System

    Second Sight Medical Products announced market entry into Singapore, with the first patient implanted with the Company’s Argus II Retinal Prosthesis System. The implantation was facilitated by t…

    Featured Content

    Contact Info

    Bryn Mawr Communications LLC
    1008 Upper Gulph Road, Suite 200
    Wayne, PA 19087

    Phone: 484-581-1800
    Fax: 484-581-1818

    Michael Jones
    Senior Editor

    Janet Burk

    About New Retina MD

    New Retina MD delivers cutting-edge content to retina specialists in their first 15 years of practice. Each issue provides fresh insight from younger physicians plus established mentors on clinical and nonclinical issues affecting ophthalmologists in the earlier stages of their careers. NRMD features surgical pearls, clinical research endeavors, practice management, medical reimbursement and policy, continuing educational requirements, financial planning, innovations, and more.